2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

…, M Baron, A Tyndall, M MatucciCerinic… - Arthritis & …, 2013 - Wiley Online Library
Objective The 1980 American College of Rheumatology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

…, P Brooks, A Brown, M MatucciCerinic… - Arthritis & …, 2011 - Wiley Online Library
Objective Remission in rheumatoid arthritis (RA) is an increasingly attainable goal, but there
is no widely used definition of remission that is stringent but achievable and could be …

Prevalence of fibromyalgia: a survey in five European countries

…, K Le Lay, C Taieb, M Matucci-Cerinic - Seminars in arthritis and …, 2010 - Elsevier
OBJECTIVE: A survey was performed in 5 European countries (France, Germany, Italy,
Portugal, and Spain) to estimate the prevalence of fibromyalgia (FM) in the general population. …

COVID-19, immune system response, hyperinflammation and repurposingantirheumatic drugs

…, AA Güler, M Matucci-Cerinic - Turkish journal of medical …, 2020 - journals.tubitak.gov.tr
In the Wuhan Province of China, in December 2019, the novel coronavirus 2019 (COVID-19)
has caused a severe involvement of the lower respiratory tract leading to an acute …

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

…, M Kuwana, Y Allanore, M Matucci-Cerinic… - The Lancet …, 2020 - thelancet.com
Background A phase 2 trial of tocilizumab showed preliminary evidence of efficacy in systemic
sclerosis. We assessed skin fibrosis and systemic sclerosis-associated interstitial lung …

Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis

…, RE Gay, U Müller-Ladner, M Matucci-Cerinic… - Circulation …, 2004 - Am Heart Assoc
Systemic sclerosis (SSc) skin lesions are characterized by disturbed vessel morphology with
enlarged capillaries and an overall reduction in capillary density, suggesting a deregulated, …

The gastric wall in systemic sclerosis patients: a morphological study

…, G Benelli, L Messerini, M Matucci-Cerinic… - Italian Journal of …, 2010 - torrossa.com
Organ failure secondary to fibrosis is the main cause of morbidity and death in patients with
systemic sclerosis. Gastrointestinal tract dysmotility is a major visceral manifestation, …

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

…, C Bocelli-Tyndall, M Matucci-Cerinic - Annals of the …, 2007 - ard.bmj.com
Background: Systemic sclerosis (SSc) is a multisystem autoimmune disease, which is classified
into a diffuse cutaneous (dcSSc) and a limited cutaneous (lcSSc) subset according to the …

Update of EULAR recommendations for the treatment of systemic sclerosis

…, D Khanna, M Matucci-Cerinic… - Annals of the …, 2017 - ard.bmj.com
The aim was to update the 2009 European League against Rheumatism (EULAR)
recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic …

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist

JH Korn, M Mayes, M Matucci Cerinic… - Arthritis & …, 2004 - Wiley Online Library
Objective Recurrent digital ulcers are a manifestation of vascular disease in patients with
systemic sclerosis (SSc; scleroderma) and lead to pain, impaired function, and tissue loss. We …